Ridge Diagnostics is a neurodiagnostic company offering its proprietary first-in-class blood test for Major Depressive Disorder (MDD) through it’s CLIA certified laboratory in North Carolina.
Based upon its proprietary Human Biomarker Library and its Biomarker Hyper-Map™ technology platform, Ridge Diagnostics researches, develops, and commercializes multi-variant biological marker
assays and diagnostic algorithms to diagnose, select and monitor treatment for Major Depressive Disorder (MDD) and other neuropsychiatric disorders.
Antidepressant drugs are among the most frequently prescribed medication in the US today where depression strikes over 19 million adults
each year – more than coronary artery disease, cancer or AIDS. For the first time, objective biological test information about depression
will aid physicians in the differential diagnosis of MDD, the selection of proper treatment and effective management of their patients.